The 52-week ELEVATE UC 52 study showed 27% clinical remission in patients taking Velsipity versus 7.4% in those who were part of the placebo group at week 12, and 32.1% clinical remission compared with 6.7% at week 52
Its widely used in wellness, performance, and medical aesthetics clinics as part of recovery, fat-burning, and rejuvenation protocols
The glucagon component drives visceral fat oxidation more aggressively, benefiting mens cardiovascular and metabolic health markers
To date, the fight against obesity has been one of the greatest challenges
These are two fundamentally different drug classes, and the mechanism difference is real and shows up in how each drug feels
Blood testing at IV Nutrition Grapevine, TX provides a clearer picture of key wellness markers including metabolic function, hormone levels, and nutrient status